Spire Healthcare Group (LON:SPI) Reaches New 52-Week High – Should You Buy?

Spire Healthcare Group plc (LON:SPI)’s share price reached a new 52-week high on Monday. The company traded as high as GBX 249.50 and last traded at GBX 248.50, with a volume of 1,619,336 shares changing hands. The stock had previously closed at GBX 249.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada lowered Spire Healthcare Group to a “sector perform” rating and lowered their price objective for the company from GBX 300 to GBX 250 in a report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Spire Healthcare Group presently has an average rating of “Moderate Buy” and a consensus price target of GBX 247.50.

Spire Healthcare Group Stock Performance

The company has a market capitalization of £993.48 million, a P/E ratio of -496.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. The firm has a 50 day moving average price of GBX 244.51 and a two-hundred day moving average price of GBX 209.46. The company has a debt-to-equity ratio of 180.14, a quick ratio of 0.73 and a current ratio of 0.58.

Spire Healthcare Group (LON:SPI) last issued its quarterly earnings data on Wednesday, September 30th. The company reported GBX (0.50) earnings per share for the quarter. Spire Healthcare Group had a negative return on equity of 0.26% and a negative net margin of 0.12%. On average, research analysts expect that Spire Healthcare Group plc will post 15.66 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.